This is a prospective, multi-center, case-control study where neurocognitive function will be evaluated in 36 patients with Cushing syndrome (CS) and 36 controls matched for age, gender and education.
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion criteria:
* Male and female patients with Cushing syndrome (CS) caused by ACTH-producing pituitary adenoma or cortisol producing adrenal adenoma
* Age between 18 and 65 years
Exclusion criteria
* CS caused by ectopic ACTH producing tumours
* CS caused by adrenocortical carcinoma
* Pseudo CS
* Subclinical CS
* Exogenous CS
* Previous history of major psychiatric disorder (not related to CS)
* Neurological disorders affecting the central nervous system
* High alcohol consumption (more than 14 units of alcohol per week)
* Active malignancy or any treatment for malignancy during the last 2 years
* Heart failure (NYHC II-IV)
* Severe respiratory insufficiency
* Severely impaired hepatic function (alanine transaminase and/or aspartate transaminase concentrations two times the upper limit of normal or above)
* Severely impaired renal function (serum- creatinine \>150 µmol/L or glomerular filtration rate \<45 ml/min)
* Pregnancy or breast feeding
* Any other illness that significantly affects the patients cognitive function according to the investigators opinion
* Contraindication for MRI (Presence of medical implants, metal in the body, claustrophobia)
Primary outcome measure(s)
Cognitive function — 2 years Improvement in memory 2 years after treatment of Cushing syndrome evaluated with the Rey Complex Figure.
Trial sites (3)
Facility
City
Region
Status
Dept of Medicine, Division of Endocrinology, and Center for Endocrine Tumors, Leiden University Medical Center
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.